D
Lantern Pharma Inc. LTRN
$3.75 -$0.18-4.58%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -42.52% -4.49% -40.67% -23.80% -39.60%
Total Depreciation and Amortization 1,194.59% 1,222.86% 1,226.47% 16.45% 27.59%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -164.47% -94.87% -43.51% -227.24% -45.59%
Change in Net Operating Assets -17.19% -144.39% 986.36% 131.19% 67.16%
Cash from Operations -54.54% -44.51% 18.33% -26.85% 10.55%
Capital Expenditure 37.50% -- 75.28% 27.14% 28.36%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 188.96% 56.74% 41.81% -57.15% 449.34%
Cash from Investing 193.61% 55.80% 42.12% -57.51% 411.42%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -- --
Foreign Exchange rate Adjustments 232.79% 276.56% -96.00% -148.48% -260.53%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -43.66% -32.69% 24.20% -76.74% 17.35%
Weiss Ratings